Search

Your search keyword '"Bettini R"' showing total 518 results

Search Constraints

Start Over You searched for: Author "Bettini R" Remove constraint Author: "Bettini R"
518 results on '"Bettini R"'

Search Results

251. Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.

252. Enantiotropically related albendazole polymorphs.

253. Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products.

254. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.

255. Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients.

256. Are pharmaceutics really going supercritical?

257. Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention.

258. Association of nicotinamide with parabens: effect on solubility, partition and transdermal permeation.

259. Doxycycline sustained release from brushite cements for the treatment of periodontal diseases.

260. Swelling, melting point reduction and solubility of PEG 1500 in supercritical CO2.

261. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.

262. Physicochemical and cell adhesion properties of chitosan films prepared from sugar and phosphate-containing solutions.

263. Isolated blunt duodenal trauma: delayed diagnosis and favorable outcome with "quadruple tube" decompression.

264. Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease.

265. Solid-state chemistry of ambroxol theophylline-7-acetate.

266. [Consensus statement of Multisocietary Task Force--prescription of physical exercise in the cardiological environment (First part)].

267. The determinant factors of recurrence following resection for ductal pancreatic cancer.

268. Primary microparticles and agglomerates of morphine for nasal insufflation.

269. Assemblage of novel release modules for the development of adaptable drug delivery systems.

270. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics.

271. Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying.

272. Cardiological guidelines for competitive sports eligibility.

273. [Cardiological protocols on evaluation of fitness for competitive sports].

274. [Essential thrombocythemia].

275. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?

276. [Prognostic value of serum beta2-microglobulin in multiple myeloma].

277. Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro.

278. The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer.

279. [Myelofibrosis with myeloid metaplasia. A study of 24 consecutive patients].

280. Drug-beta-cyclodextrin containing pellets prepared with a high-shear mixer.

281. Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin.

282. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].

283. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.

284. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].

285. Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade?

286. Skin permeation of 5-methoxypsoralen from topical dosage forms.

287. Management of functioning endocrine pancreatic tumors.

288. The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties.

289. [Effectiveness of mesoglycan in the prevention of cerebral ischemia].

290. [Effectiveness and tolerability of selegiline in the treatment of pathological cerebral involutions].

291. Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".

292. [Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy].

293. [Reaction times during citicoline treatment].

294. Influence of layer position on in vitro and in vivo release of levodopa methyl ester and carbidopa from three-layer matrix tablets.

295. Early stromal invasion in cervical cancer: immunocytochemical changes occurring in infiltrating neoplastic cells.

296. Cystic tumours of the pancreas: a review.

297. Infection prevention in necrotizing pancreatitis: an old challenge with new perspectives.

298. Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration.

299. Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide.

300. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate.

Catalog

Books, media, physical & digital resources